Average Co-Inventor Count = 4.22
ph-index = 35
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Allergan, Inc. (53 from 2,285 patents)
2. Allergan Sales, Inc. (22 from 228 patents)
3. Io Therapeutics, Inc. (7 from 72 patents)
4. Other (2 from 832,680 patents)
5. Allergen Sales, Inc. (2 from 4 patents)
86 patents:
1. 12325685 - RXR agonist salt form, polymorphs thereof, and uses thereof
2. 12115193 - Methods of using RARγ agonists for cancer treatment
3. 11976021 - Synthesis of tetrahydronaphthalenols and uses thereof
4. 11919848 - RXR agonist salt form, polymorphs thereof, and uses thereof
5. 11793835 - Methods of using RARγ agonists for cancer treatment
6. 10919835 - Compounds and synthetic methods for the preparation of retinoid X receptor-specific retinoids
7. 10590059 - Compounds and synthetic methods for the preparation of retinoid X receptor-specific retinoids
8. 9920013 - 2,5-dioxoimidazolidin-1-yl-3-urea derivatives as formyl peptide modulators
9. 9868700 - Carbamoyl hydrazine derivatives as formyl peptide modulators
10. 9663457 - Carbamoyl hydrazine derivatives as formyl peptide modulators
11. 9604934 - Urea hydantoin derivatives as formyl peptide modulators
12. 9090624 - Aromatic bycyclic derivatives as CXCR4 receptor modulators
13. 8846760 - Dihydronaphthalene and naphthalene derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators
14. 8729096 - Imidazolidine-2,4-dione derivatives as N-formyl peptide receptor 2 modulators
15. 8653299 - Dihydronaphthalene and naphthalene derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators